B2DB — Who said what, where, and when

Reuben Dawkins

Co-founder & CEO, Link Biologics

Link Biologics is pioneering first-in-class TSG-6-based biologics, delivering multi-pathway modulation of inflammation, tissue protection and repair. Lead programmes in DED and Wet AMD targeted for the clinic in 2027.

Events Reuben Dawkins has spoken at